ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Texas » Interventional Cardiology

Top Interventional Cardiology Prescribers in Texas

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
GEORGE HANNA M.D.

Interventional Cardiology

12,606

$759K

943
801 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 28%

$60
Average prescription price

Avg: $65

WAYNE MARGOLIS M.D.

Interventional Cardiology

10,200

$976K

647
534 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

33%
prescriptions for brand name drugs

Avg: 28%

$96
Average prescription price

Avg: $65

JASON BRADLEY M.D.

Interventional Cardiology

9,359

$415K

685
586 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 28%

$44
Average prescription price

Avg: $65

MICHELE DI BLASI M.D.

Interventional Cardiology

8,995

$458K

733
625 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 28%

$51
Average prescription price

Avg: $65

CHARLES NEWKIRK M.D.

Interventional Cardiology

8,978

$368K

688
629 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 28%

$41
Average prescription price

Avg: $65

MICHAEL DE LUCA MD

Interventional Cardiology

8,398

$510K

842
726 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 28%

$61
Average prescription price

Avg: $65

SURESH GADASALLI M.D.

Interventional Cardiology

7,693

$622K

846
701 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 28%

$81
Average prescription price

Avg: $65

DOUGLAS BLACK MD

Interventional Cardiology

7,627

$330K

555
426 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 28%

$43
Average prescription price

Avg: $65

PAUL TUCKER M.D.

Interventional Cardiology

7,512

$619K

575
497 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

38%
prescriptions for brand name drugs

Avg: 28%

$82
Average prescription price

Avg: $65

RONALD SCOTT M.D.

Interventional Cardiology

6,879

$289K

451
381 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 28%

$42
Average prescription price

Avg: $65

L ROUTH MD

Interventional Cardiology

6,431

$417K

540
497 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 28%

$65
Average prescription price

Avg: $65

JOHN ISAAC M.D.

Interventional Cardiology

6,282

$649K

435
404 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

40%
prescriptions for brand name drugs

Avg: 28%

$103
Average prescription price

Avg: $65

MICHAEL BLANC M.D.

Interventional Cardiology

6,142

$382K

579
491 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

31%
prescriptions for brand name drugs

Avg: 28%

$62
Average prescription price

Avg: $65

IYAD RASHDAN MD

Interventional Cardiology

6,107

$563K

528
481 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

38%
prescriptions for brand name drugs

Avg: 28%

$92
Average prescription price

Avg: $65

DOMINGO GONZALEZ MD

Interventional Cardiology

6,086

$349K

590
509 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 28%

$57
Average prescription price

Avg: $65

SHANTI NEERUKONDA M.D.

Interventional Cardiology

6,004

$224K

466
403 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

17%
prescriptions for brand name drugs

Avg: 28%

$37
Average prescription price

Avg: $65

MICHAEL FERRY MD

Interventional Cardiology

5,788

$326K

545
506 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 28%

$56
Average prescription price

Avg: $65

MICHAEL GRACEFFO MD

Interventional Cardiology

5,759

$359K

424
364 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 28%

$62
Average prescription price

Avg: $65

JOHN WILLARD MD

Interventional Cardiology

5,729

$251K

585
523 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 28%

$44
Average prescription price

Avg: $65

KURTIS KRUEGER M.D.

Interventional Cardiology

5,700

$294K

374
354 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 28%

$52
Average prescription price

Avg: $65

VASUDEV SHENOY MD

Interventional Cardiology

5,580

$293K

393
325 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

6%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 28%

$53
Average prescription price

Avg: $65

ROBERT OAKLEY M.D.

Interventional Cardiology

5,433

$432K

381
344 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

38%
prescriptions for brand name drugs

Avg: 28%

$80
Average prescription price

Avg: $65

MOISES BUCAY MD

Interventional Cardiology

5,420

$365K

429
361 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

34%
prescriptions for brand name drugs

Avg: 28%

$67
Average prescription price

Avg: $65

STEPHEN SIGAL M.D.

Interventional Cardiology

5,414

$311K

482
382 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 28%

$57
Average prescription price

Avg: $65

SAMUEL NUSSBAUMER M.D.

Interventional Cardiology

5,390

$331K

411
377 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 28%

$61
Average prescription price

Avg: $65

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank